))
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Manage episode 371449566 series 3369804
内容由Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff提供。所有播客内容（包括剧集、图形和播客描述）均由 Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
In this episode, we delve into the history of frontline treatment in young/fit patients with Hodgkin's lymphoma and recent developments in the past decade with Dr. Nancy Bartlett from Washington University.
Link for our Blood Cancer Talks Survey: https://bit.ly/BCTS
Here are the key trials we discussed:
1. RATHL Trial (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27332902/
2. S0816 (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27069074/
3. ECHELON-1 (Replacing Bleomycin by Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/29224502/
https://pubmed.ncbi.nlm.nih.gov/35830649/
4. BREACH (BV-AVD vs ABVD for Early Stage Unfavorable Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/35867960/
5. S1826 (Nivo-AVD vs BV-AVD in Advanced Hodgkin’s Lymphoma):
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4
6. FIL-ROUGE (PET-adapted ABVD vs Dose-Intensified ABVD):
https://onlinelibrary.wiley.com/doi/10.1002/hon.3163_4
7. HD21 (BRECADD vs EBEACOPP in Advanced Hodgkin’s Lymphoma):
47集单集
分享
